In this study, we demonstrated that Sestrin 2 levels were higher in both sputum supernatant and cell pellet of patients with severe asthma compared to those with milder forms of the disease, whereas neither Endocan nor SIRT1 serum levels differed between patients with different asthma severity. The gene discussed is SIRT1; the disease is asthma.